Today’s solutions.
Tomorrow’s innovations.

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share.

Whether we’re supporting emerging biotech companies or smaller, specialty pharma, our mission remains to accelerate the launch of new drugs, providing one-stop CMC services for the full lifecycle of drug development.

Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.


“Asymchem’s ability to identify and provide solutions to difficult challenges, while maintaining outstanding quality under aggressive timelines, has distinguished Asymchem as a top-notch Contract Manufacturing Organization.”

Tom Wagler, Ph.D., VP, CMC Drug Substance Development at Mersana

“ … really nice work enabling and scale-up on this compound”

Principal Scientist, in Large Pharma

“We are impressed with the high competency of all the Asymchem teams, in every aspect of the business, and this gives us lots of confidence in Asymchem.”

Director Global Procurement, at Major US Pharma company

Great work in manufacturing more than enough RSMs to meet our API demands for our CTM/Validation campaign. You did a great job controlling the purity of these materials. Thank you.

Director of Synthetic Chemistry, at a Biopharma Company
  • Asymchem Inc. Holding Company established

  • Asymchem Laboratories (Tianjin) Co., Ltd. (TJ1) established, focused on high potency, R&D, and manufacturing

  • Asymchem Laboratories (Fuxin) Co., Ltd. (FX1) dedicated to carbapenem manufacturing

  • Asymchem Life Science (Tianjin) Co., Ltd. (TJ2) started multi-dimensional operations, committed to the development of novel technology, manufacturing of cGMP intermediates, API development and formulation, plus analytic and testing services

  • Beijing Branch of Asymchem Laboratories (Tianjin) Co.,Ltd. (TICCR BJ) established for business development

  • Jilin Asymchem Laboratories Co., Ltd. (DH1) dedicated to commercial cGMP manufacturing

  • Asymchem Shanghai business office established dedicated to business development

  • Asymchem IPO on the Shenzhen Stock Exchange (002821)

  • Liaoning Asymchem Laboratories Co., Ltd. (FX2) dedicated to back Integration non-GMP manufacturing

  • Jilin Asymchem Pharmaceuticals Co., Ltd. (DH2) under construction

  • Tianjin Asymchem Medical Science & Technology Co., Ltd. (TICCR) established as a clinical CRO

  • Tianjin Asymchem Pharmaceuticals Co., Ltd. (TJ3) dedicated to API and drug product manufacturing

  • Asymchem Limited established in United Kingdom dedicated to business development

  • Shanghai Asymchem Scientific Co., Ltd. established to provide biological testing related services

  • Beijing branch of Tianjin Asymchem Medical Science & Technology Co., Ltd. dedicated to clinical trial support established

  • Shanghai Asymchem Biologics Co., Ltd. established

  • Tianjin Clin-nov Medical Technology Co., Ltd. Established to provide full-cycle project management services for pre-clinical and phase I-IV clinical research

  • Beijing Branch of Tianjin Clin-nov Medical Technology Co., Ltd. Established for Clinical Drug Trials, Bioequivalence Service, and China-based medicine registration

  • Asymchem Laboratories (Jilin) Co., Ltd. for API & Drug Product Manufacturing

  • Asymchem Pharmaceuticals (Jiangsu) Co., Ltd., Manufacturing and R&D Center of Small Molecules Drug

Solutions, innovations, and know how delivered to your inbox.
Sign up for our newsletter!